Browse 4 obviousness type double patenting cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
Settlement Agreement Unenforceable Due to Lack of Mutual Assent
Colage v. Collins, decided by Federal Circuit on December 3, 2025, resulted in a defendant win outcome. The case concerns the enforceability of a settlement agreement in a patent infringement dispute....
Federal Circuit Affirms Non-Infringement of MS Drug Patent
Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., decided by Federal Circuit on October 30, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck Serono's patent for...
Federal Circuit Affirms Patent Infringement for Schizophrenia Drug
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...
CAFC Affirms Biosimilar Infringement Finding for Ruxolitinib Patents
Incyte Corporation v. Sun Pharmaceutical Industries, Ltd., decided by Federal Circuit on May 7, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Sun Pharma's proposed bi...
CaseLawBrief currently tracks 4 obviousness type double patenting cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 2, Plaintiff Win: 2.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.